Molina Healthcare, Inc. (NYSE:MOH) Shares Bought by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP raised its stake in Molina Healthcare, Inc. (NYSE:MOH) by 22.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 470,932 shares of the company’s stock after purchasing an additional 84,929 shares during the period. Dimensional Fund Advisors LP owned about 0.80% of Molina Healthcare worth $140,026,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently bought and sold shares of MOH. Innealta Capital LLC acquired a new stake in Molina Healthcare in the 2nd quarter valued at about $36,000. Ashton Thomas Private Wealth LLC acquired a new stake in Molina Healthcare in the 2nd quarter valued at about $40,000. Principal Securities Inc. acquired a new stake in Molina Healthcare in the 4th quarter valued at about $42,000. AM Squared Ltd acquired a new stake in Molina Healthcare in the 2nd quarter valued at about $59,000. Finally, Mather Group LLC. acquired a new stake in shares of Molina Healthcare during the 1st quarter worth about $123,000. Institutional investors and hedge funds own 98.50% of the company’s stock.

Molina Healthcare Trading Up 0.4 %

MOH opened at $351.42 on Friday. The business’s 50 day moving average is $335.60 and its two-hundred day moving average is $343.15. Molina Healthcare, Inc. has a 52 week low of $282.96 and a 52 week high of $423.92. The firm has a market cap of $20.59 billion, a price-to-earnings ratio of 19.07, a price-to-earnings-growth ratio of 1.20 and a beta of 0.57. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 0.49.

Molina Healthcare (NYSE:MOH) last announced its earnings results on Wednesday, July 24th. The company reported $5.86 earnings per share for the quarter, beating the consensus estimate of $5.73 by $0.13. Molina Healthcare had a return on equity of 28.09% and a net margin of 2.84%. The company had revenue of $9.88 billion for the quarter, compared to the consensus estimate of $9.75 billion. During the same period last year, the business posted $5.65 EPS. The company’s revenue was up 18.7% on a year-over-year basis. On average, research analysts predict that Molina Healthcare, Inc. will post 23.5 EPS for the current year.

Insider Buying and Selling at Molina Healthcare

In other Molina Healthcare news, Director Steven J. Orlando sold 1,000 shares of Molina Healthcare stock in a transaction that occurred on Tuesday, July 30th. The stock was sold at an average price of $339.21, for a total value of $339,210.00. Following the transaction, the director now directly owns 18,025 shares in the company, valued at approximately $6,114,260.25. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other Molina Healthcare news, Director Steven J. Orlando sold 1,000 shares of Molina Healthcare stock in a transaction that occurred on Tuesday, July 30th. The stock was sold at an average price of $339.21, for a total value of $339,210.00. Following the transaction, the director now directly owns 18,025 shares in the company, valued at approximately $6,114,260.25. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Maurice Hebert sold 393 shares of Molina Healthcare stock in a transaction that occurred on Thursday, August 15th. The shares were sold at an average price of $346.52, for a total value of $136,182.36. Following the completion of the transaction, the chief accounting officer now owns 9,473 shares in the company, valued at $3,282,583.96. The disclosure for this sale can be found here. Company insiders own 1.10% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on the company. Jefferies Financial Group cut their target price on Molina Healthcare from $354.00 to $297.00 and set a “hold” rating on the stock in a research report on Wednesday, July 24th. Truist Financial cut their target price on Molina Healthcare from $440.00 to $400.00 and set a “buy” rating on the stock in a research report on Monday, July 15th. StockNews.com lowered Molina Healthcare from a “buy” rating to a “hold” rating in a research report on Wednesday. TD Cowen cut their target price on Molina Healthcare from $412.00 to $351.00 and set a “buy” rating on the stock in a research report on Wednesday, July 24th. Finally, Robert W. Baird assumed coverage on Molina Healthcare in a research report on Thursday, May 30th. They set an “outperform” rating and a $405.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, Molina Healthcare currently has an average rating of “Hold” and a consensus target price of $378.00.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.